Quantcast

Latest Allergic conjunctivitis Stories

2011-05-11 15:28:00

NASHVILLE, Tenn., May 11, 2011 /PRNewswire/ -- Many Kentuckians are suffering this allergy season from red, swollen or itchy eyes. The allergens in the air during spring and early summer can cause allergy sufferers to dread seemingly simple activities, like taking your child for a walk outdoors. According to the Asthma and Allergy Foundation of America, approximately 40 million Americans have indoor/outdoor allergies, and of that 40 million, approximately four percent suffer from...

2011-05-11 15:25:00

LOUISVILLE, Ky., May 11, 2011 /PRNewswire/ -- Many Kentuckians are suffering this allergy season from red, swollen or itchy eyes. The allergens in the air during spring and early summer can cause allergy sufferers to dread seemingly simple activities, like taking your child for a walk outdoors. According to the Asthma and Allergy Foundation of America, approximately 40 million Americans have indoor/outdoor allergies, and of that 40 million, approximately four percent suffer from allergies...

2010-12-14 06:30:00

IRVINE, Calif., Dec. 14, 2010 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it has initiated a Phase 2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group environmental study will evaluate the safety and efficacy of bepotastine besilate, dosed twice daily, in patients presenting...

2010-10-16 11:15:00

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. ISTA expects to launch BROMDAY (formerly referred...

2010-10-15 16:08:00

IRVINE, Calif., Oct. 15 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today announced it will release third quarter 2010 financial results after market close on November 2, 2010. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time focusing on its commercial progress and pipeline updates, conducting a question and answer session after each set of formal comments. Date: Tuesday, November 2, 2010 Time: 4:30 p.m. Eastern...

2010-10-06 06:30:00

IRVINE, Calif., Oct. 6 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced positive preliminary results from a Phase 1/2 clinical study of bepotastine besilate nasal spray conducted in Canada for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The findings demonstrated two of the three bepotastine besilate concentrations tested were effective in relieving patients' nasal...

2010-09-27 06:30:00

IRVINE, Calif., Sept. 27 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA) today highlighted results from the Company's REMURA(TM) (bromfenac ophthalmic solution for dry eye) Phase 2 clinical study. The study achieved statistical significance in the primary endpoint of the objective sign of conjunctival staining (p<0.001) as compared to baseline. The study also achieved statistical significance on the objective sign of corneal staining (p<0.01) as compared to...

2010-09-06 13:55:00

ANTONY, France, September 6, 2010 /PRNewswire-FirstCall/ -- Stallergenes S.A. has announced today the signing of exclusive partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen immunotherapy tablet products resulting from the Stalair(R) program: Actair(R) house dust mite tablets and Japanese cedar pollen tablets. With 32 million respiratory allergy sufferers, there is a strong - and as yet unmet - demand for treatment in Japan, where sublingual allergen...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related